Senores Pharmaceuticals Financials
NSE: SENORES | BSE: 544319
₹1,428.40
As on 04-Sep-2026 15:54IST
Market cap
₹6,572 Cr
Revenue (TTM)
₹692 Cr
P/E Ratio
52
P/B Ratio
6.8
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
691.72
|
632.63
|
398.25
|
214.52
|
35.34
|
14.17
|
|||||
|
Total Income
|
721.39
|
679.69
|
417.51
|
217.34
|
39.02
|
14.63
|
|||||
|
Total Expenditure
|
486.96
|
464.31
|
308.55
|
172.95
|
22.67
|
12.22
|
|||||
|
EBITDA
|
204.76
|
168.32
|
89.70
|
41.57
|
12.67
|
1.95
|
|||||
|
Depreciation
|
35.19
|
31.25
|
16.84
|
10.00
|
1.78
|
0.71
|
|||||
|
EBIT
|
169.57
|
137.07
|
72.86
|
31.57
|
10.89
|
1.25
|
|||||
|
Interest
|
27.15
|
25.03
|
21.55
|
9.45
|
2.14
|
0.57
|
|||||
|
Other Income
|
29.67
|
47.06
|
19.26
|
2.82
|
3.68
|
0.46
|
|||||
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
172.09
|
159.10
|
70.57
|
24.94
|
12.44
|
1.14
|
|||||
|
Provision for Tax
|
41.27
|
37.57
|
12.23
|
-7.77
|
4.00
|
0.15
|
|||||
|
Profit after Tax
|
130.82
|
121.53
|
58.34
|
32.71
|
8.43
|
0.99
|
|||||
|
Minority Interest
|
-4.45
|
-6.16
|
0.22
|
-1.25
|
--
|
--
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
126.37
|
115.37
|
58.56
|
31.46
|
8.43
|
0.99
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
933.60
|
933.60
|
786.18
|
204.27
|
45.50
|
36.59
|
|||||
|
Minority Interest
|
-4.45
|
30.94
|
26.06
|
27.44
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
215.27
|
215.27
|
155.25
|
127.73
|
33.67
|
12.23
|
|||||
|
Current Liabilities
|
424.00
|
424.00
|
240.70
|
247.50
|
51.88
|
9.88
|
|||||
|
Total Liabilities
|
1,603.81
|
1,603.81
|
1,226.86
|
621.89
|
131.05
|
59.15
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
763.06
|
791.38
|
485.76
|
356.03
|
79.72
|
31.65
|
|||||
|
Current Assets
|
812.43
|
812.43
|
722.43
|
250.91
|
51.34
|
27.05
|
|||||
|
Total Assets
|
1,603.81
|
1,603.81
|
1,226.86
|
621.89
|
131.05
|
59.15
|
|||||
|
Total Debt*
|
--
|
327.09
|
304.76
|
248.39
|
60.76
|
14.21
|
|||||
|
Net Current Assets
|
388.43
|
388.43
|
481.73
|
3.41
|
-0.55
|
17.17
|
|||||
|
Contingent Liabilities
|
--
|
24.43
|
20.93
|
22.97
|
8.35
|
--
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
62.05
|
-45.92
|
-25.70
|
-1.08
|
-10.45
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-120.56
|
-429.48
|
-54.23
|
-48.29
|
-24.44
|
|||||
|
Cash from Financing Activities
|
--
|
-1.33
|
573.13
|
86.98
|
46.25
|
36.46
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
-59.84
|
97.73
|
7.05
|
-3.12
|
1.58
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
27.44
|
25.05
|
12.72
|
10.31
|
8.59
|
1.13
|
|||||
|
Cash EPS (₹)
|
27.44
|
33.18
|
16.33
|
14.00
|
10.40
|
1.94
|
|||||
|
Adjusted Book Value (₹)
|
209.27
|
202.67
|
170.72
|
66.95
|
46.36
|
41.86
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
13.47
|
-9.97
|
-8.42
|
-1.10
|
-11.95
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
-55.11
|
-47.07
|
-24.63
|
-52.65
|
-24.61
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
15.66
|
11.94
|
12.31
|
18.56
|
3.36
|
|||||
|
ROE (%)
|
14.46
|
14.14
|
11.78
|
26.19
|
20.55
|
2.71
|
|||||
|
ROA (%)
|
9.24
|
8.64
|
6.43
|
8.86
|
8.89
|
1.69
|
|||||
|
EBIT Margin (%)
|
24.51
|
21.67
|
18.30
|
14.72
|
30.82
|
8.80
|
|||||
|
Net Margin (%)
|
18.13
|
17.88
|
13.97
|
15.05
|
21.61
|
6.77
|
|||||
|
Cash Profit Margin (%)
|
--
|
24.15
|
18.88
|
19.91
|
28.90
|
11.97
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
53.57
|
58.85
|
85.65
|
507.07
|
149.38
|
--
|
|||||
|
EBIT Growth (%)
|
117.98
|
88.13
|
130.79
|
189.87
|
773.38
|
--
|
|||||
|
Net Profit Growth (%)
|
87.05
|
108.31
|
78.36
|
287.88
|
750.96
|
--
|
|||||
|
EPS Growth (%)
|
74.33
|
97.01
|
23.33
|
20.01
|
657.94
|
--
|
|||||
|
Book Value Growth (%)
|
--
|
18.71
|
284.87
|
348.95
|
24.35
|
--
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
52.01
|
30.25
|
45.04
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
6.82
|
3.74
|
3.35
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
28.75
|
16.98
|
23.47
|
5.99
|
4.31
|
8.18
|
|||||
|
Close Price (₹)
|
1,329.90
|
759.60
|
570.60
|
--
|
--
|
--
|
|||||
|
High Price (₹)
|
1,360.00
|
876.50
|
665.00
|
--
|
--
|
--
|
|||||
|
Low Price (₹)
|
558.55
|
440.30
|
391.00
|
--
|
--
|
--
|
|||||
|
Market Cap (₹ Cr)
|
6,572.31
|
3,490.16
|
2,637.53
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.21
|
0.35
|
0.39
|
1.22
|
1.34
|
0.39
|
|||||
|
Short term debt to equity ratio
|
--
|
0.03
|
0.04
|
0.16
|
0.18
|
0.05
|
|||||
|
Current Ratio
|
1.92
|
1.92
|
3.00
|
1.01
|
0.99
|
2.74
|
|||||
|
Quick Ratio
|
1.71
|
1.71
|
2.77
|
0.86
|
0.93
|
2.44
|
|||||
|
Interest Coverage
|
7.34
|
7.36
|
4.27
|
3.64
|
6.82
|
3.02
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
46.96
|
51.34
|
31.11
|
52.21
|
62.56
|
138.54
|
|||||
|
Asset Turnover
|
0.49
|
0.45
|
0.44
|
0.58
|
0.37
|
0.24
|
|||||
|
Receivable days
|
--
|
129.44
|
108.09
|
114.09
|
215.56
|
505.67
|
|||||
|
Inventory Days
|
--
|
42.09
|
43.08
|
34.45
|
31.54
|
76.84
|
|||||
|
Payable days
|
--
|
218.97
|
182.04
|
217.67
|
296.18
|
324.20
|
|||||
|
Cash Conversion Cycle
|
--
|
-47.43
|
-30.87
|
-69.13
|
-49.08
|
258.30
|